GSE108464 AZ-628 1 v 9 human up (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE108464_AZ-628_1_v_9_human_up.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE108464_AZ-628_1_v_9_human_up.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE108464_AZ-628_1_v_9_human_up.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE108464_AZ-628_1_v_9_human_up.

Results found

Linked to

 

Label

Description

 

Gene

S100 calcium binding protein P

Gene

aldo-keto reductase family 1 member C3

Gene

aquaporin 3 (Gill blood group)

Gene

heme oxygenase 1

Gene

aldo-keto reductase family 1 member C2

Gene

secretory leukocyte peptidase inhibitor

Gene

cytochrome P450 family 1 subfamily B member 1

Gene

argininosuccinate synthase 1

Gene

eukaryotic translation initiation factor 5A

Gene

transmembrane 4 L six family member 1

  • Gene

    S100 calcium binding protein P


  • Gene

    aldo-keto reductase family 1 member C3


  • Gene

    aquaporin 3 (Gill blood group)


  • Gene

    heme oxygenase 1


  • Gene

    aldo-keto reductase family 1 member C2


  • Gene

    secretory leukocyte peptidase inhibitor


  • Gene

    cytochrome P450 family 1 subfamily B member 1


  • Gene

    argininosuccinate synthase 1


  • Gene

    eukaryotic translation initiation factor 5A


  • Gene

    transmembrane 4 L six family member 1

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.